Evaluations of the Selectivities of the Diacylglycerol Kinase Inhibitors R59022 and R59949 Among Diacylglycerol Kinase Isozymes Using a New Non-Radioactive Assay MethodMayu Sato, Fumio Sakane, Ke Liu et al.|Pharmacology|2013Cited by 94
A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune responseKe Liu, Fumio Sakane, Megumi Sakuma et al.|Journal of Lipid Research|2016Cited by 78